Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Trading 05-19 09:59:29 EDT

874.87

+7.40

+0.85%

High875.41	Low865.68	Vol86.12M
Open867.47	D1 Closing867.47	Amplitude1.12%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O1.22B	T/O Rate--	Tradable Shares0.00
P/B5.166201	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":874.8664,"timestamp":1779199169805,"preClose":867.46796,"halted":0,"volume":86118694,"delay":0,"changeRate":0.008529,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":7.398438,"latestTime":"05-19 09:59:29 EDT","open":867.4681,"high":875.4084,"low":865.6803,"amount":1218141348.516995,"amplitude":0.011214,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1779220800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.166201,"peRate":26.076785,"turnoverRate":0.001958,"increases":73,"decrements":108,"flats":7,"marketCap":3425161194415.875,"floatMarketCap":3273083072262.5625},"requestUrl":"/m/hq/s/BK4007/wiki","defaultTab":"wiki","newsList":[{"id":"2636585849","title":"Ebola deaths in eastern Congo rise to 131 as outbreak spreads","url":"https://stock-news.laohu8.com/highlight/detail?id=2636585849","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636585849?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:05","pubTimestamp":1779188712,"startTime":"0","endTime":"0","summary":"UPDATE 1-Ebola deaths in eastern Congo rise to 131 as outbreak spreadsMore than 500 suspected Ebola cases documented Cases in urban areas raise concerns about spreadExposed Americans to be evacuated to Germany Experts explore treatment and vaccine options Adds border controls in paragraphs 6-8, WHO representative's comments in paragraphs 13, 19, 21By Erikas Mwisi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL6N41W0NX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","LU2433249047.HKD","IE00B1BXHZ80.USD","IE00BSNM7G36.USD","LU2360032135.SGD","LU2491049909.HKD","LU0861579265.USD","IE0009355771.USD","LU0320765489.SGD","SG9999002224.SGD","LU2491050154.USD","LU1934455277.USD","SG9999014559.SGD","LU1929549753.HKD","IE00BFTCPJ56.SGD","IE00BBT3K403.USD","LU1699723380.USD","LU2324357040.USD","LU0234572021.USD","LU0203347892.USD","LU2089984988.USD","BK4534","BK4585","LU0985320562.USD","LU1291159041.SGD","LU1989771016.USD","LU2106854487.HKD","LU0208291251.USD","BK4559","LU1066051811.HKD","LU1989772840.SGD","LU0122379950.USD","LU2125154778.USD","LU1023059063.AUD","SG9999002232.USD","LU2112291526.USD","LU1162221912.USD","LU0130517989.USD","LU1069347547.HKD","LU1941712348.USD","LU0130102774.USD","LU0965509010.AUD","IE00B2B36J28.USD","SG9999014575.USD","BK4516","BK4533","LU0965508806.USD","BK4550","LU1037948897.HKD","LU1430594728.SGD","LU1057294990.SGD","LU0965509283.SGD","LU0432979614.USD","BK4007","LU1066053197.SGD","SG9999013999.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","LU1116320737.USD","LU1974910355.USD","LU1983299246.USD","LU2461242641.AUD","LU2023250843.SGD","LU1934455194.USD","LU0648001328.SGD","LU1201861249.SGD","LU1941712264.USD","LU1585245621.USD","LU1923622614.USD","MRK","LU0266013472.USD","IE000M9KFDE8.USD","LU1093756168.USD","LU2491050071.SGD","LU2125909247.SGD","SG9999001440.SGD","LU1066051498.USD","LU1093756325.SGD","LU0965509101.SGD","SG9999015358.SGD","LU2023250504.SGD","LU0070302665.USD","IE00BLSP4452.SGD","IE0002141913.USD","LU0868494708.USD","IE00BLSP4239.USD","LU1061106388.HKD","SG9999014567.USD","SGXZ57979304.SGD","LU2125154935.USD","SG9999014542.SGD","SG9999001176.SGD","LU0265550359.USD","LU0211331839.USD","IE00B4R5TH58.HKD","LU2361044865.SGD","LU0980610538.SGD","LU1934455863.HKD","LU0477156953.USD","LU2468319806.SGD","LU0868494617.USD","SG9999015341.SGD","LU0859254822.USD","BK4588","LU0238689110.USD","LU0203345920.USD","LU1037948541.HKD","LU1116320901.HKD","LU2357627491.SGD","LU0106261372.USD","LU0098860793.USD","LU1571399168.USD","LU2125909593.SGD","LU1066051225.USD","LU2361044949.HKD","LU2361045086.USD","IE00BN8TJ469.HKD","LU0265550946.USD","SG9999001176.USD","LU0058720904.USD","LU0942090050.USD","LU1035773651.USD","LU0320765646.SGD","LU0289739699.SGD","LU1989772923.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858913","title":"Harrow director Adrienne Graves acquires 1,000 common shares for $31,070","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858913","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636858913?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:01","pubTimestamp":1779188480,"startTime":"0","endTime":"0","summary":"Harrow director Adrienne L. Graves reported a purchase of 1,000 common shares at USD 31.07.Her direct holdings rose to 1,000 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harrow Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL8pYg5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4557","HROW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636996858","title":"Harrow director Lauren Silvernail acquires $31,000 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2636996858","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636996858?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:01","pubTimestamp":1779188473,"startTime":"0","endTime":"0","summary":"Harrow director Lauren P. Silvernail bought 1,000 common shares in an open-market purchase at USD 31 per share.Her direct holding rose to 1,000 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harrow Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL67LCnF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Harrow director Lauren Silvernail acquires $31,000 in common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HROW","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858153","title":"EyePoint Announces Participation at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858153","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636858153?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., May  19, 2026  (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297309/0/en/EyePoint-Announces-Participation-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0889565916.HKD","BK4007","EYPT","LU0109394709.USD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636581558","title":"PMET Resources Receives Government-Backed Letters of Support for Shaakichiuwaanaan Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636581558","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636581558?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":"MONTREAL, May 19, 2026 /PRNewswire/ -- May 19, 2026 – Sydney, Australia. PMET has received non-binding letters of support from Export Development Canada , Germany's KfW IPEX-Bank and another major Canadian Government financial institution as part of advancing its ongoing financing strategy for the Shaakichiuwaanaan Project.EDC is Canada's export credit agency and a Government of Canada-owned financial Crown corporation which facilitated more than C$10 billion in business across the Canadian resources sector in 2024. EDC is a leading provider of financing solutions to the Canadian mining sector and strategic export industries.Ken Brinsden, CEO and Managing Director, comments: \"Shaakichiuwaanaan continues to stand out as one of the most strategically positioned critical mineral projects globally, underpinned by its scale, premier jurisdiction, infrastructure advantages and multi-commodity critical minerals potential. The interest shown by leading government-backed and Canadian financial ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pmet-resources-receives-government-backed-letters-of-support-for-shaakichiuwaanaan-financing-302774883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PMETF","BK4168","PMT.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636159858","title":"XORTX Announces Closing of US$5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2636159858","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636159858?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":"CALGARY, Alberta , May  19, 2026  (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (\"XORTX\" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297319/0/en/XORTX-Announces-Closing-of-US-5-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","XRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636185838","title":"Biofrontera Inc : Benchmark Cuts to Speculative Buy From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2636185838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636185838?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:53","pubTimestamp":1779188017,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41V1P2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858809","title":"Clearmind agrees to convert $600,000 notes into common shares at $0.3 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858809","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636858809?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:52","pubTimestamp":1779187949,"startTime":"0","endTime":"0","summary":"Clearmind Medicine set terms to convert USD 600,000 of outstanding Convertible Notes into common shares.The parties agreed to a fixed conversion price of USD 0.3 per share, overriding the notes’ conversion-price formula.The conversion implies issuance of 2,000,000 common shares, subject to rounding under the notes.The Floor Price definition in the form of Convertible Note under the securities purchase agreement was amended to USD 0.3 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL74cb13:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636830068","title":"Wave Life Sciences Ltd : H.c. Wainwright Cuts Target Price to $13 From $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2636830068","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636830068?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:45","pubTimestamp":1779187516,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0B5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WVE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636830531","title":"Planet 13 wins Florida OMMU approval for BHO extraction facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2636830531","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636830531?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:30","pubTimestamp":1779186658,"startTime":"0","endTime":"0","summary":"Planet 13 received Florida Office of Medical Marijuana Use clearance for its BHO extraction facility in Florida, enabling entry into the state’s full concentrate category.The 3,465-square-foot lab is expected to support multiple BHO concentrate formats and vape products, with roll-out planned in coming months pending product approvals.Florida’s concentrate segment generated about USD 125 million in retail sales, based on Headset data.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL6n9plv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","SG9999014039.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","LU2210150020.SGD","PLNH","BK4585","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014021.USD","BK4112","NDAQ","IE00B64PRP62.GBP","BK4007","IE00B3QW5Z07.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636830376","title":"Planet 13 Receives Ommu Approval for Florida Bho Extraction Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2636830376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636830376?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:30","pubTimestamp":1779186640,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W08K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PLNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636299830","title":"Alterity Therapeutics Data Underpin Phase 3 Advancement of ATH434 in Multiple System Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2636299830","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636299830?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:30","pubTimestamp":1779186629,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($ATHE) ) has shared an announcement. On May 19, 2026, Alterity Therapeutics reported new clinical and imaging data for ATH...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-data-underpin-phase-3-advancement-of-ath434-in-multiple-system-atrophy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-data-underpin-phase-3-advancement-of-ath434-in-multiple-system-atrophy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636283053","title":"Immunic names Michael Bonney board chair, replacing interim chair Simona Skerjanec","url":"https://stock-news.laohu8.com/highlight/detail?id=2636283053","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636283053?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:30","pubTimestamp":1779186623,"startTime":"0","endTime":"0","summary":"Immunic appointed Michael W. Bonney as chair of the board, effective May 16, 2026.Simona Skerjanec moved from interim chair to remain a board member.Bonney previously held senior commercial leadership roles at Biogen, where he worked on the launch and growth of Avonex for multiple sclerosis.He later served as CEO of Cubist Pharmaceuticals for more than 10 years, leading commercialization of Cubicin and the company’s sale to Merck for about USD 9.5 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL2rXf4K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","IE00B2B36J28.USD","SG9999001176.SGD","BK4559","SG9999013999.USD","BK4533","LU0130102774.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU0109394709.USD","LU0965509010.AUD","SG9999015358.SGD","LU0208291251.USD","LU2361044865.SGD","LU1983299246.USD","LU1941712348.USD","LU0006306889.USD","LU0234570918.USD","SG9999002232.USD","LU1069347547.HKD","LU1571399168.USD","LU2361045086.USD","IE00B19Z9Z06.USD","LU0648001328.SGD","LU0889565916.HKD","LU1989772923.USD","SG9999001176.USD","LU1923622614.USD","LU2125909247.SGD","LU0477156953.USD","LU1066051498.USD","LU1934455863.HKD","LU1941712264.USD","BK4532","LU2023250504.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU1057294990.SGD","LU0965509101.SGD","LU2125909593.SGD","IE00B894F039.SGD","LU0985320562.USD","SG9999014559.SGD","LU2357627491.SGD","LU1035773651.USD","LU2089984988.USD","SG9999014575.USD","BK4516","LU1093756168.USD","LU2125154935.USD","LU0058720904.USD","LU0320765992.SGD","LU1162221912.USD","SG9999014542.SGD","LU0861579265.USD","IMUX","LU2361044949.HKD","BK4585","IE00B19Z9P08.USD","BK4588","LU0106261372.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0130517989.USD","IE00BBT3K403.USD","IE0002141913.USD","LU0265550946.USD","LU1974910355.USD","IE00BN8TJ469.HKD","BK4139","LU2360032135.SGD","LU0320765646.SGD","LU2491050071.SGD","LU0965508806.USD","LU1201861249.SGD","LU1917777945.USD","LU0942090050.USD","LU0098860793.USD","LU1066051811.HKD","LU1066051225.USD","BK4007","LU0980610538.SGD","LU1023059063.AUD","LU0203347892.USD","LU0238689110.USD","LU0211331839.USD","LU1291159041.SGD","LU1699723380.USD","LU1989771016.USD","LU0203345920.USD","LU0965509283.SGD","LU0122379950.USD","LU0320765489.SGD","LU2468319806.SGD","IE00B1BXHZ80.USD","SG9999002224.SGD","LU0266013472.USD","LU1116320737.USD","LU1989772840.SGD","LU2491049909.HKD","LU1037948897.HKD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU2491050154.USD","LU1061106388.HKD","LU1934455194.USD","LU0432979614.USD","LU1116320901.HKD","SG9999014567.USD","LU2023250843.SGD","IE00BLSP4452.SGD","LU1934455277.USD","LU2125154778.USD","LU1093756325.SGD","LU2324357040.USD","LU2112291526.USD","LU2106854487.HKD","LU0265550359.USD","LU2433249047.HKD","LU0868494708.USD","LU0859254822.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU1929549753.HKD","LU0289739699.SGD","BK4550","IE0009355771.USD","LU0868494617.USD","SG9999015341.SGD","LU1430594728.SGD","LU0234572021.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636583719","title":"Viatris Is Maintained at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2636583719","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636583719?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:13","pubTimestamp":1779185580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VTRS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2026 06:13 ET (10:13 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","LU2087621335.USD","BK4007","BK4588","BK4585","BK4583","VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636837792","title":"Clearmind Medicine announces 1-for-10 reverse share split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636837792","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636837792?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:10","pubTimestamp":1779185436,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced that it will conduct a reverse share split of its issued and outstanding common shares, no par value, at a rati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-1-for-10-reverse-share-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-medicine-announces-1-for-10-reverse-share-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636832063","title":"Merck & Co Files Pricing Term Sheet for Notes Offering of up to $6.00 Bln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636832063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636832063?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:03","pubTimestamp":1779185023,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41V1JI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2461242641.AUD","SGXZ57979304.SGD","SG9999014559.SGD","LU1037948897.HKD","LU1585245621.USD","LU2491050071.SGD","LU0477156953.USD","LU0289739699.SGD","LU2023250504.SGD","LU0130102774.USD","LU0985320562.USD","LU2125154778.USD","IE0002141913.USD","SG9999001440.SGD","BK4550","LU1934455277.USD","BK4533","BK4559","LU0130517989.USD","LU1934455863.HKD","LU1201861249.SGD","SG9999014567.USD","LU2106854487.HKD","IE00B4R5TH58.HKD","LU0070302665.USD","LU1162221912.USD","LU2361045086.USD","BK4534","BK4516","LU2433249047.HKD","LU0965509010.AUD","LU0238689110.USD","LU2112291526.USD","LU0265550946.USD","LU1929549753.HKD","LU1066051498.USD","LU1430594728.SGD","LU1035773651.USD","LU1699723380.USD","LU0980610538.SGD","IE00B1BXHZ80.USD","LU1983299246.USD","LU2491049909.HKD","SG9999002232.USD","LU2361044949.HKD","LU1974910355.USD","IE000M9KFDE8.USD","LU1941712348.USD","LU0861579265.USD","LU0942090050.USD","LU1291159041.SGD","BK4007","IE00BLSP4239.USD","LU1934455194.USD","LU1116320737.USD","LU0868494617.USD","LU1066051811.HKD","IE00BLSP4452.SGD","LU1093756325.SGD","LU2089984988.USD","IE00BBT3K403.USD","LU0211331839.USD","SG9999014542.SGD","LU2023250843.SGD","LU0122379950.USD","SG9999002224.SGD","LU0965508806.USD","SG9999001176.USD","LU1571399168.USD","SG9999015341.SGD","LU0006306889.USD","BK4585","LU0203345920.USD","LU0432979614.USD","LU0965509283.SGD","LU1069347547.HKD","LU2491050154.USD","LU1917777945.USD","LU1057294990.SGD","LU1061106388.HKD","IE00B2B36J28.USD","LU2357627491.SGD","LU2125909593.SGD","IE00BFTCPJ56.SGD","MRK","LU1989772840.SGD","LU2361044865.SGD","IE0009355771.USD","LU2125909247.SGD","SG9999015358.SGD","LU2468319806.SGD","BK4588","SG9999013999.USD","LU0320765489.SGD","LU0265550359.USD","LU0859254822.USD","LU1066051225.USD","LU0208291251.USD","LU1989771016.USD","LU1989772923.USD","LU0965509101.SGD","IE00BJT1NW94.SGD","LU2125154935.USD","LU1093756168.USD","LU1037948541.HKD","LU1116320901.HKD","LU1066053197.SGD","LU0320765646.SGD","IE00BN8TJ469.HKD","SG9999001176.SGD","LU1923622614.USD","LU0203347892.USD","LU2360032135.SGD","SG9999014575.USD","IE00BSNM7G36.USD","LU0098860793.USD","LU0648001328.SGD","LU2324357040.USD","LU0868494708.USD","LU0266013472.USD","LU1941712264.USD","LU0234572021.USD","LU1023059063.AUD","LU0106261372.USD","LU0058720904.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636087832","title":"Clearmind Medicine to execute 1-for-10 reverse stock split May 21","url":"https://stock-news.laohu8.com/highlight/detail?id=2636087832","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636087832?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:02","pubTimestamp":1779184964,"startTime":"0","endTime":"0","summary":"Clearmind Medicine will execute a 1-for-10 reverse share split effective May 21, 2026.The move targets renewed compliance with Nasdaq’s minimum bid price requirement.Issued and outstanding common shares are expected to drop to about 1,019,033 from 10,190,337, with fractional shares rounded up to whole shares.Outstanding options and warrants will be adjusted proportionately for share count and exercise price.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL7mg7js:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014021.USD","CMND","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","SG9999014039.USD","BK4112","BK4585","BK4007","LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014005.SGD","NDAQ","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636832209","title":"BRIEF-Clearmind Medicine Announces 1-For-10 Reverse Share Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636832209","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636832209?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:00","pubTimestamp":1779184850,"startTime":"0","endTime":"0","summary":"BRIEF-Clearmind Medicine Announces 1-For-10 Reverse Share SplitMay 19 (Reuters) - Clearmind Medicine Inc CMND.O:CLEARMIND MEDICINE ANNOUNCES 1-FOR-10 REVERSE SHARE SPLITCLEARMIND MEDICINE INC - REVERS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA4SQZLL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636683225","title":"Clearmind Medicine Announces 1-for-10 Reverse Share Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636683225","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636683225?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:00","pubTimestamp":1779184801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA4SQZLL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636832920","title":"Who Representative in Congo: Merck & Co’s  Ervebo Is One of the Potential Vaccines That Could Provide Prevention and Protection Against Ebola","url":"https://stock-news.laohu8.com/highlight/detail?id=2636832920","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636832920?lang=en_us&edition=fundamental","pubTime":"2026-05-19 17:56","pubTimestamp":1779184614,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL6N41W0LC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001440.SGD","LU0130517989.USD","LU0106261372.USD","LU2089984988.USD","LU0965509283.SGD","LU0208291251.USD","LU2125154778.USD","LU1066051811.HKD","SG9999015341.SGD","LU0238689110.USD","LU0289739699.SGD","LU1571399168.USD","LU2461242641.AUD","IE00BFTCPJ56.SGD","LU1162221912.USD","LU0234572021.USD","IE00B2B36J28.USD","BK4585","LU0098860793.USD","SG9999014575.USD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU1066051498.USD","BK4534","LU1023059063.AUD","LU1430594728.SGD","LU2106854487.HKD","SG9999001176.SGD","LU1069347547.HKD","LU2361044949.HKD","LU2360032135.SGD","LU0203345920.USD","SG9999014559.SGD","LU2361044865.SGD","LU0965508806.USD","LU1037948897.HKD","LU2491049909.HKD","LU0122379950.USD","SGXZ57979304.SGD","LU0320765489.SGD","LU0211331839.USD","IE00BLSP4239.USD","IE0009355771.USD","LU1093756168.USD","LU1116320737.USD","LU0985320562.USD","LU1941712348.USD","LU0070302665.USD","LU0859254822.USD","LU1066053197.SGD","LU1989771016.USD","IE00BJT1NW94.SGD","LU0006306889.USD","IE00BJJMRZ35.SGD","LU2433249047.HKD","LU1116320901.HKD","LU0861579265.USD","IE0002141913.USD","LU2125154935.USD","IE00BN8TJ469.HKD","LU0130102774.USD","LU1585245621.USD","LU0965509010.AUD","BK4550","LU1093756325.SGD","IE00BBT3K403.USD","SG9999013999.USD","LU0266013472.USD","BK4559","LU1934455277.USD","IE000M9KFDE8.USD","LU0980610538.SGD","SG9999014567.USD","LU0320765646.SGD","LU0058720904.USD","LU0432979614.USD","LU1989772923.USD","LU0265550946.USD","LU1929549753.HKD","LU1035773651.USD","LU0265550359.USD","LU1061106388.HKD","LU1291159041.SGD","LU0965509101.SGD","LU1923622614.USD","LU2324357040.USD","MRK","IE00BLSP4452.SGD","LU2125909593.SGD","LU1057294990.SGD","LU2361045086.USD","LU1699723380.USD","LU1201861249.SGD","LU1983299246.USD","LU2357627491.SGD","SG9999015358.SGD","LU2112291526.USD","SG9999001176.USD","BK4007","IE00B1BXHZ80.USD","SG9999002224.SGD","LU0868494708.USD","LU0868494617.USD","BK4533","LU2491050154.USD","SG9999002232.USD","BK4516","LU2468319806.SGD","LU1934455194.USD","LU1066051225.USD","LU2023250843.SGD","SG9999014542.SGD","LU1941712264.USD","LU0203347892.USD","LU2125909247.SGD","IE00BSNM7G36.USD","LU0942090050.USD","LU1037948541.HKD","LU1917777945.USD","LU1934455863.HKD","BK4588","LU1974910355.USD","LU1989772840.SGD","LU2491050071.SGD","LU0648001328.SGD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction